Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Completed · Not applicable

Conditions studied: Non-small Cell Lung Cancer

In brief

The main purpose of this study is to compare two types of treatment-standard palliative care (which usually is given towards the end of life) and integrated palliative care (which is given soon after diagnosis) to see which is better for improving quality of life of participants with advanced non-small cell lung cancer. Palliative care is care that tries to lessen the symptoms of a disease. Although many people with advanced lung cancer receive palliative care or hospice toward the end of their disease, the entire course of their disease is often complicated by physical and emotional difficulties. Palliative care may be useful when it is started soon after diagnosis.

Key facts

Study ID

NCT01038271

Run by

Massachusetts General Hospital

People needed

151

Starts

2006-05-01

Expected to finish

2017-01-01

Last updated by the study team

2018-03-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically or cytologically confirmed incurable NSCLC, stage IIIB with a pleural or pericardial effusion or stage IV
• Performance status 0-2
• Diagnosis of advanced NSCLC within the previous eight weeks
• Ability to read and respond to questions in English
• Permission of attending physician

You may not qualify if…

• Prior chemotherapy for metastatic disease
• Existence of other co-morbid disease, which in the opinion of the investigator prohibits participation in the protocol

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.